Search Results

Metformin/pioglitazone a dominant diabetes strategy

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 584, 2009-08-08 , pp. 7-7(1)

Publisher: Adis International

Effects of early use of pioglitazone in combination with metformin in patients with newly diagnosed type 2 diabetes

Authors: Chalmers, J.; Hunter, J.E.; Robertson, S.J.; Baird, J.; Martin, M.; Franks, C.I.; Whately-Smith, C.R.; Mariz, S.; Campbell, I.W.

Source: Current Medical Research and Opinion, Volume 23, Number 8, August 2007 , pp. 1775-1781(7)

Publisher: Informa Healthcare

Metformin/pioglitazone [Competact] has been launched in the UK by Takeda for the treatment of type 2 diabetes mellitus

Source: Inpharma, Volume 1, Number 1559, 2006-10-14 , pp. 22-22(1)

Publisher: Adis International

Pioglitazone/Metformin

Authors: Deeks, Emma D.; Scott, Lesley J.

Source: Drugs, Volume 66, Number 14, 2006 , pp. 1863-1877(15)

Publisher: Adis International

Pioglitazone/Metformin: A Viewpoint by David R. Matthews

Author: Matthews, David R.

Source: Drugs, Volume 66, Number 14, 2006 , pp. 1878-1880(3)

Publisher: Adis International

Pioglitazone/Metformin: A Viewpoint by Guntram Schernthaner

Author: Schernthaner, Guntram

Source: Drugs, Volume 66, Number 14, 2006 , pp. 1878-1880(3)

Publisher: Adis International

Pioglitazone/Metformin: A Viewpoint by Marc Rendell

Author: Rendell, Marc

Source: Drugs, Volume 66, Number 14, 2006 , pp. 1878-1880(3)

Publisher: Adis International

EU product approvals

Source: Inpharma, Volume 1, Number 1551, 2006-08-19 , pp. 22-22(1)

Publisher: Adis International

Other EU regulatory news

Source: Inpharma, Volume 1, Number 1543, 2006-06-24 , pp. 22-22(1)

Publisher: Adis International

US product launches

Source: Inpharma, Volume 1, Number 1513, 2005-11-12 , pp. 18-18(1)

Publisher: Adis International

US product approvals

Source: Inpharma, Volume 1, Number 1504, 2005-09-10 , pp. 22-22(1)

Publisher: Adis International